Peer Coaching for Low-Income Patients With Diabetes in Primary Care

This study has been completed.
Sponsor:
Collaborator:
American Academy of Family Physicians
Information provided by (Responsible Party):
Thomas Bodenheimer, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01040806
First received: December 28, 2009
Last updated: December 9, 2011
Last verified: December 2011
  Purpose

Patients with diabetes who are counseled by a peer coach (another patient with diabetes) will have improved glycemic control compared with usual care patients.


Condition Intervention
Diabetes Type 2
Behavioral: Usual care
Behavioral: Health coaching

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Peer Coaching for Low-Income Patients With Diabetes in Primary Care

Resource links provided by NLM:


Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • HbA1c level [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • LDL cholesterol level [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Enrollment: 300
Study Start Date: August 2009
Study Completion Date: May 2011
Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Health coaching
Patients with poorly controlled diabetes will receive counseling from a peer health coach -- a patient with diabetes trained in health coaching
Behavioral: Health coaching
Peer health coaches will counsel patients with diabetes
Other Names:
  • Peer coaching
  • Peer coach
  • Peer support
Active Comparator: Usual care
Patients will receive usual care
Behavioral: Usual care
Patients will receive their usual medical care

Detailed Description:

Peer coaches have controlled diabetes, patient study subjects have poorly controlled diabetes.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diabetes with most recent HbA1c 8 or above in past 6 months.

Exclusion Criteria:

  • Dementia,
  • Life expectancy less than 6 months,
  • Inability to speak English or Spanish.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01040806

Locations
United States, California
San Francisco General Hospital
San Francisco, California, United States, 94110
Sponsors and Collaborators
University of California, San Francisco
American Academy of Family Physicians
Investigators
Principal Investigator: Thomas Bodenheimer, MD University of California, San Francisco
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Thomas Bodenheimer, Adjunct Professor of Family and Community Medicine, University of California, San Francisco
ClinicalTrials.gov Identifier: NCT01040806     History of Changes
Other Study ID Numbers: H40013-34104-01
Study First Received: December 28, 2009
Last Updated: December 9, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, San Francisco:
Diabetes

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on October 20, 2014